These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36. Study design and rationale of the heterotopic implantation of the Edwards-Sapien XT transcatheter valve in the inferior VEna cava for the treatment of severe tricuspid regurgitation (HOVER) trial. O'Neill BP; Wheatley G; Bashir R; Edmundowicz D; O'Murchu B; O'Neill WW; Patil P; Chen A; Forfia P; Cohen HA Catheter Cardiovasc Interv; 2016 Aug; 88(2):287-93. PubMed ID: 27122473 [TBL] [Abstract][Full Text] [Related]
37. Transcatheter interventions for tricuspid regurgitation: the FORMA Repair System. Puri R; Rodés-Cabau J EuroIntervention; 2016 Sep; 12(Y):Y113-5. PubMed ID: 27640021 [No Abstract] [Full Text] [Related]
38. Intermediate term hemodynamic effects of single inferior vena cava valve implant for the treatment of severe tricuspid regurgitation. Rakita V; Lakhter V; Patil P; O'Neill BP Catheter Cardiovasc Interv; 2017 Sep; 90(3):521-525. PubMed ID: 28168785 [TBL] [Abstract][Full Text] [Related]
39. Transcatheter interventions for tricuspid regurgitation - heterotopic technology: TricValve. Figulla HR; Kiss K; Lauten A EuroIntervention; 2016 Sep; 12(Y):Y116-8. PubMed ID: 27640022 [No Abstract] [Full Text] [Related]
40. Transvenous, antegrade Melody valve-in-valve implantation for bioprosthetic mitral and tricuspid valve dysfunction: a case series in children and adults. Cullen MW; Cabalka AK; Alli OO; Pislaru SV; Sorajja P; Nkomo VT; Malouf JF; Cetta F; Hagler DJ; Rihal CS JACC Cardiovasc Interv; 2013 Jun; 6(6):598-605. PubMed ID: 23683739 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]